Available to all, everywhere.

Take Action for a People's Vaccine

The fairest and most effective way to end this pandemic is to ensure that everyone, everywhere has access to COVID-19 vaccines, tests and treatments. But pharmaceutical company monopolies could leave countries in the global south waiting until 2023 for widespread vaccination. This leaves us all in danger from new variants which may make current vaccines ineffective.

Join the Action

Read our demands

1. Petition

People around the world are calling for a #PeoplesVaccine – freely available to everyone, everywhere. Join them!

Restricting vaccine supply to protect profits during a pandemic will cost countless lives. The more the virus is left to circulate, the greater the chance of new variants emerging and our current vaccines becoming ineffective.

This is unacceptable and threatens us all: no-one is safe until everyone is safe.

We can address vaccine inequity by temporarily waiving intellectual property rights to vaccines and by encouraging pharmaceutical companies to share their know-how, so that the manufacture of vaccines can be scaled up to meet demand.

Call on the Irish government now to take a stand for fairness, equality and global health. Sign this petition now.

Sign the Petition

* indicates required
Do you wish to receive updates on this campaign? *

2. Tweet Politicians

Choose your constituency

4. Our Virtual Launch!

People’s Vaccine Alliance Ireland

On the 8 July 2021 we marked the official launch of our national campaign for a People’s Vaccine with over 300 guests.

A recording of the event and clips of our guest speakers are available now. So make sure you share the important insight and messages our guest speakers, including Dr. Mike Ryan from the WHO and Winnie Byanyima from UNAIDS, shared at our launch.

Read more about our launch event guest speakers here.

View clips of our guest speakers

Our Demands to the Irish Government

  1. Ireland must use its voice within the EU to support the TRIPS waiver - Call on governments to temporarily suspend intellectual property rights at the World Trade Organisation for COVID-19 vaccines, treatments and diagnostics. This will help break Big Pharma monopolies and increase supplies so there are enough doses for everyone, everywhere. For more info, click here and here.

  2. Ireland must endorse the World Health Organisation (WHO) COVID Technology Access Pool (C-TAP) to facilitate the sharing of know-how by Pharmaceutical companies to increase vaccine production. For more info click here.

Join the Action

‘Solidarity, in an inter-dependent world, must mean . . . standing shoulder to shoulder with those in other countries, especially poorer nations with fewer financial resources, so that, for example, vaccines are made available, accessible and affordable for all.’

NO-ONE IS SAFE

UNTIL EVERYONE IS SAFE.

Inventor of the polio vaccine, Jonas Salk, when asked who owned the patent of his life saving discovery replied:


Well, the people I would say. There is no patent. Could you patent the sun?

FAQ's

Pharmaceutical corporations use patents and other intellectual property rights to stop other companies from making the vaccines or medicines they have developed. We are saying that in these unprecedented times, companies should share their knowledge and not enforce intellectual property rights in the interests of public health.

But intellectual property is not the only barrier. Vaccines are not as straightforward as many other medicines to copy and many are made of biological material. Therefore, it is important that corporations and research institutions also share the know-how, biological material and technology behind their vaccine with other companies that could manufacture them. We have seen some bilateral examples of this. For example, Astra Zeneca has licensed production to companies in India, Brazil and in Argentina. However, this process should not be left to the goodwill of individual corporations or subject to secretive deals. The WHO COVID-19 Technology Access Pool (C-TAP) provides a global mechanism for such sharing. The C-TAP can promote technology transfer and the licensing of production to more companies and institutions that are able to manufacture safe and effective vaccines in order to maximise supply.

This is simply not true. Experienced vaccine manufacturers who are willing to make hundreds of millions of doses have come forward from all over the world to say they are ready to produce if intellectual property barriers were removed and the vaccine recipe and know-how shared.

COVAX is an advanced procurement and distribution programme which aims to secure access for poorer countries. While it is encouraging that at least 170 countries have agreed to work together under COVAX, this programme does not aim to increase vaccine manufacturing capacity and has fallen considerable short of its modest target to vaccinate 30% adult population because the extra vaccines simply are not there, due to artificial constraints on expanding manufacturing capacity.



More frequently asked questions can be found here

A People’s Vaccine

bottle

AVAILABLE TO ALL, EVERYWHERE.



We are all thankful that Ireland’s vaccine roll out is gathering speed, but it must be remembered that the global pandemic is far from over.


Thousands of people are dying of the COVID-19 virus every day in countries without sufficient access to the vaccine.

The science is clear: The fairest and most effective way to end this pandemic is to ensure that everyone, everywhere has access to COVID-19 vaccines.

Global access to COVID-19 vaccines is also in our self-interest as ongoing outbreaks anywhere mean greater risk of new variants developing against which our vaccines may not be effective.

There simply is no way to defeat COVID-19 in Ireland without united action worldwide. But pharmaceutical company monopolies could leave countries in the global south waiting until 2023 for widespread vaccination and this is where we would ask for your support.

In order to produce sufficient vaccines for everyone globally, we need to greatly increase manufacturing capacity and all suitably qualified vaccine manufacturers must be permitted to produce vaccines free from patents and pharmaceutical companies must agree to share their know-how. We need a People’s Vaccine.